CFHR2 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test
Introduction
The CFHR2 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test is a cutting-edge diagnostic tool that utilizes Next Generation Sequencing (NGS) technology to analyze the CFHR2 gene. This test is vital for identifying genetic predispositions to hemolytic uremic syndrome (HUS), a serious condition characterized by the destruction of red blood cells, acute kidney failure, and low platelet count. Understanding your genetic risk can significantly impact your health management and treatment strategies.
What the Test Measures
This test specifically detects mutations in the CFHR2 gene, which can lead to HUS. By analyzing the genetic material, healthcare providers can determine if an individual carries variants associated with an increased risk of developing this syndrome.
Who Should Consider This Test
Individuals who may benefit from the CFHR2 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test include:
- Those with a family history of hemolytic uremic syndrome.
- Patients displaying symptoms such as unexplained anemia, kidney dysfunction, and low platelet counts.
- Individuals with known risk factors for HUS, including certain infections or underlying health conditions.
Benefits of Taking the Test
Taking the CFHR2 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test offers several advantages:
- Early identification of genetic risks allows for proactive health management.
- Guides treatment decisions and monitoring strategies for at-risk individuals.
- Provides valuable information for family planning and genetic counseling.
Understanding Your Results
Results from the CFHR2 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test will indicate whether any mutations were detected. A genetic counselor will help interpret the results, explaining their implications for your health and guiding you through the next steps.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 400,000 NGN |
| Regular Price | 560,000 NGN |
Booking Your Test
To book the CFHR2 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with scheduling your appointment and answering any questions you may have.
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The test requires a sample of blood, extracted DNA, or a drop of blood on an FTA card. It is recommended to have a clinical history reviewed and a genetic counseling session to draw a pedigree chart of family members affected by the CFHR2 gene.
This test falls under the specialty of General Physician, within the Genetics department, and is relevant for conditions related to Hepatology, Nephrology, and Endocrinology Disorders.
